FDA clears Travere’s FILSPARI for expanded use in rare kidney disease

FDA grants priority review to Daiichi Sankyo & Merck’s lung cancer drug application

The investigational therapy, ifinatamab deruxtecan, is a potential first-in-class B7-H3 directed DXd antibody drug conjugate discovered by Daiichi Sankyo and jointly developed with Merck

DCDC Kidney Care launches Academy of Healthcare to build India’s dialysis workforce

New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education

Microbot Medical begins full US market release of LIBERTY endovascular robotic system

Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology

Bisleri expands CSR support for rural mental health programme in MP

Three-year CSR partnership to scale community-led mental healthcare access across Chhindwara district

CDSCO invites bids for next-gen Digital Drugs Regulatory System

API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India

Regeneron and Telix strike major radiopharma pact in push into next-gen cancer therapies

The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio

FDA presses 2,200+ companies to fix missing clinical trial results

Move amid evidence of widespread reporting gaps

Vir Biotechnology advances VIR-5500 into expansion trials in prostate cancer

Pinky Promise opens first physical clinic in Mumbai, expands women’s hybrid healthcare model

AI-enabled women’s digital clinic brings in-person consultations to complement app-led care after serving over 400,000 women across India